V8T-22285-07390 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-05-28
Dose 1 — Pfizer-BioNTech
2022-06-09
Registered in v-safe
2022-06-24
Dose 2 — Pfizer-BioNTech
2022-06-25
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site bruising — Feeling: Fair · Site: Swelling · Fatigue or tiredness

Free text: Bruise at injection site

MedDRA releases: 2024-11 · check-in free text available
2022-07-31
Survey response — day 35, dose 2
MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: COVID

MedDRA releases: 2024-11 · check-in free text available
2022-07-31
Report sent to call center — day 35, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-08-01
Call successful
Not applicable - Accidental Reporting
2022-08-07
Survey response — day 42, dose 2
MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: COVID

MedDRA releases: 2024-11 · check-in free text available
2022-08-07
Report sent to call center — day 42, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-08-08
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-05-28	Pfizer-BioNTech	No
2	2022-06-24	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-07-31	Successful 2022-08-01	Not applicable - Accidental Reporting
2022-08-07	Successful 2022-08-08	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 12 — days 1–6 daily, dose 2

2022-06-25

Systemic reaction (other): Bruise at injection site

Release 12 — day 35, dose 2

2022-07-31

Symptoms: COVID

Release 12 — day 42, dose 2

2022-08-07

Symptoms: COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SRO	Injection site bruising	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release